Wall Street analysts expect Coherent (COHR) to post quarterly earnings of $0.42 per share in its upcoming report, which indicates a year-over-year decline of 27.6%. Revenues are expected to be $1.17 billion, down 5.8% from the year-ago quarter. Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective. Given this perspective, it's time to examine the average forecasts of specific Coherent metrics that are routinely monitored and predicted by Wall Street analysts. According to the collective judgment of analysts, 'Revenues- Networking' should come in at $564.08 million. The estimate suggests a change of +2.4% year over year. The combined assessment of analysts suggests that 'Revenues- Lasers' will likely reach $354.46 million. The estimate indicates a year-over-year change of -3%. The collective assessment of analysts points to an estimated 'Revenues- Materials' of $260.01 million. The estimate indicates a change of -19.7% from the prior-year quarter. View all Key Company Metrics for Coherent here>>> Shares of Coherent have demonstrated returns of -7.3% over the past month compared to the Zacks S&P 500 composite's -4.1% change. With a Zacks Rank #3 (Hold), COHR is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Coherent Corp. (COHR):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Wall Street's Insights Into Key Metrics Ahead of Coherent (COHR) Q3 Earnings
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...